doi: 10.1158/0008-5472.CAN-05-3034.
Cancer risk assessment at the atomic level
Affiliations
- PMID: 16488985
- DOI: 10.1158/0008-5472.CAN-05-3034
Item in Clipboard
Cancer risk assessment at the atomic level
Cancer Res.
.
Abstract
A flurry of articles on the structure of different domains of BRCA1 and BRCA2 have not only shed light on the biology of these proteins but have also raised hopes that these data could eventually be used to infer cancer association for a large number of inherited missense mutations whose effect on protein function is unclear.
Similar articles
-
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9. Breast Cancer Res Treat. 2006. PMID: 16847550
-
Clinical management of BRCA1 and BRCA2 mutation carriers.Nat Clin Pract Oncol. 2006 Jan;3(1):2-3. doi: 10.1038/ncponc0384. Nat Clin Pract Oncol. 2006. PMID: 16407858 No abstract available.
-
Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.Cancer Res. 2004 Jun 1;64(11):3790-7. doi: 10.1158/0008-5472.CAN-03-3009. Cancer Res. 2004. PMID: 15172985
-
Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.J Clin Oncol. 2007 Jul 10;25(20):2921-7. doi: 10.1200/JCO.2007.11.3449. J Clin Oncol. 2007. PMID: 17617523 Review.
-
[Familial breast cancer genes].Nihon Rinsho. 2007 Jun 28;65 Suppl 6:601-5. Nihon Rinsho. 2007. PMID: 17682216 Review. Japanese. No abstract available.
Cited by
-
Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.Am J Hum Genet. 2018 Feb 1;102(2):233-248. doi: 10.1016/j.ajhg.2017.12.013. Epub 2018 Jan 25. Am J Hum Genet. 2018. PMID: 29394989 Free PMC article.
-
Molecular modeling indicates distinct classes of missense variants with mild and severe XLRS phenotypes.Hum Mol Genet. 2013 Dec 1;22(23):4756-67. doi: 10.1093/hmg/ddt329. Epub 2013 Jul 11. Hum Mol Genet. 2013. PMID: 23847049 Free PMC article.
-
Functional impact of missense variants in BRCA1 predicted by supervised learning.PLoS Comput Biol. 2007 Feb 16;3(2):e26. doi: 10.1371/journal.pcbi.0030026. Epub 2006 Dec 28. PLoS Comput Biol. 2007. PMID: 17305420 Free PMC article.
-
Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.Eur J Hum Genet. 2008 Jul;16(7):820-32. doi: 10.1038/ejhg.2008.13. Epub 2008 Feb 20. Eur J Hum Genet. 2008. PMID: 18285836 Free PMC article.
-
Missense variants of uncertain significance (VUS) altering the phosphorylation patterns of BRCA1 and BRCA2.PLoS One. 2013 May 21;8(5):e62468. doi: 10.1371/journal.pone.0062468. Print 2013. PLoS One. 2013. PMID: 23704879 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
